Squamous Cell Carcinoma of the Penis
📧 Sign up to get email alerts when something new happens for Squamous Cell Carcinoma of the Penis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Sacituzumab Govitecan With or Without Atezolizumab Immunotherapy in Rare Genitourinary Tumors (SMART) Such as High Grade Neuroendocrine Carcinomas, Adenocarcinoma, and Squamous Cell Bladder/Urinary Tract Cancer, Renal Medullary Carcinoma and Penile C... [Phase 2]
A Phase 2 clinical trial (SMART) is assessing sacituzumab govitecan with or without atezolizumab in rare genitourinary tumors and is current…
-
CLINICAL_TRIALS trial_result · 2025-09-24Clinical Trial Update: Contemporary Characteristics of Penile Cancer
This clinical trial update reports that the study NCT04996849 on contemporary characteristics of penile cancer has been terminated.
-
CLINICAL_TRIALS trial_result · 2025-06-26Clinical Trial Update: Avelumab With Valproic Acid in Virus-associated Cancer [Phase 2]
Phase 2 trial evaluating the PD-L1 inhibitor avelumab in combination with valproic acid for virus-associated cancers has completed; the upda…
-
CLINICAL_TRIALS trial_result · 2022-02-17Clinical Trial Update: PEN-866 in Patients With Advanced Solid Malignancies [Phase 1, Phase 2]
Clinical trial update for PEN-866 across multiple phases investigating advanced solid malignancies, including endometrial adenocarcinoma and…
-
CLINICAL_TRIALS trial_result · 2021-05-14Clinical Trial Update: Dacomitinib (PF-00299804) in Advanced/Metastatic Squamous Cell Carcinoma of the Penis [Phase 2]
Phase 2 trial investigating dacomitinib (PF-00299804) in advanced/metastatic squamous cell carcinoma of the penis has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.